Drug development

AbGenomics Corp.
2F, No. 36, Lane 358
Juikuang Rd, Neihu
Taipei 114, Taiwan

Part of the AbGenomics Group, including AbGenomics International Inc., a clinical-stage biopharmaceutical company located in the San Francisco Bay Area.

Involved in the discovery and development of therapeutic antibodies for immune-related inflammatory diseases, allergy, asthma, transplantation rejection, and cancer.

Lead candidate AbGn-168H (Neihulizumab) has demonstrated the proof of clinical efficacy in Phase II clinical trials for T-cell mediated diseases such as psoriasis and psoriatic arthritis.

– na –
Allgenesis Biotherapeutics Inc.
7F-1, No. 760, Sec. 4, Bade Rd, Songshan Dist, Taipei 105, Taiwan

Aims to discover, develop and bring to market novel small and large molecule drugs, with a focus on CNS and ophthalmology. Focus is on compound lead optimization to early clinical development.

– na –
Andros Pharmaceuticals Co., Ltd.
6F, No. 22, Sec. 2, Shengyi Rd, Zhubei City, Hsinchu County 30261, Taiwan
(Bldg D, 6F, Biotechnology Building, Hsinchu Biomedical Science Park)

Creating new drug dosage forms using lipid-based microencapsulation for topical delivery and non-viral gene delivery systems.

30261新竹縣竹北市生醫路2段22號6F (新竹生物醫學園區生技大樓D棟6F)
– na –
AP Biosciences, Inc.
17F, No. 3, Park St, Nangang Dist, Taipei 115 , Taiwan

Developing fully-human antibody-based biologics with novel mechanisms to fulfill unmet medical needs through proof-of-concept studies.

Has produced a portfolio of biologic leads with a primary clinical focus on cancer, autoimmune, and inflammatory diseases.

– na –
Asclepiumm Taiwan Co., Ltd.
Mackay Memorial Hospital Innovation & Incubation Center, No. 45, Minsheng Rd, Tamsui, New Taipei City 25160, Taiwan
+886-2-2809-4661 ext. 3066

New drug development for cancer and eye diseases.

– na –
BELX Bio-Pharmaceutical Corp.
Rm. 536, Bldg. 52, 195, Sec. 4, Chunghsing Rd, Chutung, Hsinchu, 31040, Taiwan
+886-3-591-0151 ext. 208

Developing botanically-derived new drugs to treat tumors and chronic liver diseases.

新竹縣竹東鎮中興路4段195號 (工研院育成中心52館536室)
– na –
Bora Pharmaceuticals Co., Ltd.
6F, No. 69, Xingai Rd, Neihu Dist, Taipei City 114, Taiwan

Covers the entire pharmaceutical supply chain from research and development to sales and distribution. Provides outsourced R&D and manufacturing services for domestic and multinational pharmaceutical companies. PIC/S certified.

– na –
BRIM Biotechnology, Inc.
8F, No. 1, Alley 30, Lane 358, Ruiguang Rd, Neihu Dist, Taipei 11492, Taiwan

Virtually operating company, focusing on developing new drugs in various areas including oncology and infectious disease. Focusing on translational medicine stage of drug development, team surveys many small molecules, peptides, biologics, and platform technologies at the lead optimization stage. Projects are brought into BRIM through co-development partnerships or in-licensing deals, and development of the projects is conducted at global CROs and CMOs that fit the needs of the project. Once clinical proof of concept (POC) is reached, the projects are partnered out for further clinical development.

– na –
Celtec Inc.
3F, No. 65, Ln. 77, Xingai Rd, Neihu Dist, Taipei 114, Taiwan

Developer of immunotherapy for cancer treatment

– na –
China Chemical & Pharmaceutical Co., Ltd.
No. 23, Hsiang Yang Rd., Taipei 10046, Taiwan

Primarily generic pharmaceuticals. Strategy is to provide niche and high manufacturing complexity API and generic drugs, as well as 505(b)(2) class new drugs (new route of administration, new derivatives, new use, etc.).

Six manufacturing facilities in Taiwan.

Affiliates include:
Chunghwa Chemical Synthesis & Biotech Co., Ltd.: API manufacturer
Suzhou Chunghwa Chemical & Pharmaceutical Industrial Co., Ltd. (China)
Suzhou Chunghwa Yuming Pharmaceutical Co., Ltd. (China)
Chunghwa Yuming Healthcare Co., Ltd. (drug distribution)
Chunghwa Senior Care Co., Ltd. (seniors health care services)
Phermpep Co., Ltd. (peptide-based products for health)
Tai Rung Development Co., Ltd. (packaging products, ampoules, etc.)